Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Devon Energy Corp (DVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Devon Energy Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Devon Energy Corp trades at $48.74 (market cap $52.67B). The key difference: Devon Energy Corp is far larger — about 11.2× Definium Therapeutics Inc. Common Shares's market cap, and Devon Energy Corp pays a 2.67% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Devon Energy Corp for 136 Days on average.
| DFTX | DVN | |
|---|---|---|
Market Cap | $4.71B | $52.67B |
Volume | 1,966,636 | 5,542,360 |
Sector | Health | Energy |
52-Week High | $48.45 | $52.07 |
52-Week Low | $10.68 | $31.74 |
Typical Hold Time | 0 Days | 136 Days |
Enterprise Value | $3.67B | $63.40B |
Dividend Yield | — | 2.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Devon Energy (DVN) trades at $48.92, up 1.87% today, with a bullish technical signal from moving averages and strong analyst support. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, while maintaining solid profitability with a 16.67% net margin. Recent news highlights activist investor pressure for strategic alternatives, including a potential sale, and ongoing M&A interest in its assets.
The outlook remains positive given undervaluation versus peers (P/E 10.41), a consensus price target of $62.40 implying 27% upside, and projected revenue growth to $19.7B in 2026. Key risks include oil price volatility, execution of asset sales, and debt levels, but institutional bullishness (71.9% buy ratings) underscores confidence in the Permian-focused strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →
